Results 21 to 30 of about 318,819 (293)
Cytokine release syndrome in severe COVID-19 [PDF]
Lessons from arthritis and cell therapy in cancer patients point to therapy for severe ...
Moore, John B., June, Carl H.
openaire +2 more sources
Сytokine release syndrome is the common complication of CAR-T therapy. We report a case of patient with B-cell acute lymphoblastic leukemia developing сytokine release syndrome with shock and multiple organ failure and requiring cytokine removal and ...
Antonina E. Shchekina +9 more
doaj +1 more source
The purpose of this systematic review was to describe the characteristics of clinical trials that focused on COVID-19 patients with cytokine release syndrome (CRS) and the variability in CRS definitions.
Khalid Eljaaly +5 more
doaj +1 more source
Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy [PDF]
A paradigm shift has recently occurred in the field of cancer therapeutics. Traditional anticancer agents, such as chemotherapy, radiotherapy and small-molecule drugs targeting specific signalling pathways, have been joined by cellular immunotherapies based on T cell engineering.
Emma C. Morris +3 more
openaire +3 more sources
The Many Faces of JAKs and STATs Within the COVID-19 Storm
The positive-sense single stranded RNA virus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), resulted in a global pandemic with horrendous health and economic consequences not seen in a century.
Alice H. Grant +8 more
doaj +1 more source
The new coronavirus disease 2019 (COVID-19) could be associated with elevated inflammatory cytokine levels, suggesting the involvement of cytokine release syndrome.
Cid Ould Ouali +10 more
doaj +1 more source
Enhanced release of elastase is not concomitant with increased secretion of granulocyte-activating cytokines in whole blood from patients with sepsis [PDF]
Die Diskussion am Ende des Artikels wurde gelöscht (§137l UrhG).Background The proteolytic enzyme elastase released by granulocytes (polymorphonuclear leukocytes [PMN]) in high concentrations during sepsis causes degradation of essential plasma proteins,
Ertel, Wolfgang +6 more
core +1 more source
COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue
SARS-CoV-2 has claimed 2,137,908 lives in more than a year. Some COVID-19 patients experience sudden and rapid deterioration with the onset of fatal cytokine storm syndrome (CSS), which have increased interest in CSS’s mechanisms, diagnosis and therapy ...
Xi Yongzhi
doaj +1 more source
Rituximab induced pulmonary edema managed with extracorporeal life support [PDF]
Though rare, rituximab has been reported to induce severe pulmonary edema. We describe the first report of ECLS utilization for this indication. A 31-year-old female with severe thrombotic thrombocytopenic purpura developed florid pulmonary edema after ...
Aguilar, Patrick +6 more
core +3 more sources
Highly sensitive in vitro cytokine release assay incorporating high-density preculture
Immunostimulatory effects of monoclonal antibodies (mAb) through binding to Fcγ receptors (FcγR) on immune cells are a likely cause of cytokine release syndrome.
Shiho Ito +5 more
doaj +1 more source

